Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 3 |
2023 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7.
Lancet Neurol. 2023.
PMID: 37059507
Clinical Trial.
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders.
Verschuuren JJ, Palace J, Murai H, Tannemaat MR, Kaminski HJ, Bril V.
Verschuuren JJ, et al.
Lancet Neurol. 2022 Feb;21(2):189-202. doi: 10.1016/S1474-4422(21)00463-4.
Lancet Neurol. 2022.
PMID: 35065041
Review.
Item in Clipboard
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
Chia R, Saez-Atienzar S, Murphy N, Chiò A, Blauwendraat C; International Myasthenia Gravis Genomics Consortium; Roda RH, Tienari PJ, Kaminski HJ, Ricciardi R, Guida M, De Rosa A, Petrucci L, Evoli A, Provenzano C, Drachman DB, Traynor BJ.
Chia R, et al.
Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):e2108672119. doi: 10.1073/pnas.2108672119.
Proc Natl Acad Sci U S A. 2022.
PMID: 35074870
Free PMC article.
Item in Clipboard
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.
Guptill JT, Benatar M, Granit V, Habib AA, Howard JF Jr, Barnett-Tapia C, Nowak RJ, Lee I, Ruzhansky K, Dimachkie MM, Cutter GR, Kaminski HJ; for MGNet Clinical Trial Outcome Measure Working Group.
Guptill JT, et al.
Neurology. 2023 Sep 5;101(10):442-451. doi: 10.1212/WNL.0000000000207278. Epub 2023 Apr 19.
Neurology. 2023.
PMID: 37076302
Free PMC article.
Item in Clipboard
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.
Green JD, Barohn RJ, Bartoccion E, Benatar M, Blackmore D, Chaudhry V, Chopra M, Corse A, Dimachkie MM, Evoli A, Florence J, Freimer M, Howard JF, Jiwa T, Kaminski HJ, Kissel JT, Koopman WJ, Lipscomb B, Maestri M, Marino M, Massey JM, McVey A, Mezei MM, Muppidi S, Nicolle MW, Oger J, Pascuzzi RM, Pasnoor M, Pestronk A, Provenzano C, Ricciardi R, Richman DP, Rowin J, Sanders DB, Siddiqi Z, Soloway A, Wolfe GI, Wulf C, Drachman DB, Traynor BJ.
Green JD, et al.
BMJ Open. 2020 Sep 18;10(9):e037909. doi: 10.1136/bmjopen-2020-037909.
BMJ Open. 2020.
PMID: 32948566
Free PMC article.
Review.
Item in Clipboard
The best and worst of times in therapy development for myasthenia gravis.
Benatar M, Cutter G, Kaminski HJ.
Benatar M, et al.
Muscle Nerve. 2023 Jan;67(1):12-16. doi: 10.1002/mus.27742. Epub 2022 Nov 12.
Muscle Nerve. 2023.
PMID: 36321730
Free PMC article.
Item in Clipboard
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey.
Macaluso M, Rothenberg ME, Ferkol T, Kuhnell P, Kaminski HJ, Kimberlin DW, Benatar M, Chehade M; Principal Investigators of the Rare Diseases Clinical Research Network – Cycle 4.
Macaluso M, et al.
JMIR Public Health Surveill. 2024 Feb 14;10:e48430. doi: 10.2196/48430.
JMIR Public Health Surveill. 2024.
PMID: 38354030
Free PMC article.
Item in Clipboard
Cite
Cite